Expression of antibodies using single‐open reading frame vector design and polyprotein processing from mammalian cells
Authors:
- 10 April 2009
- journal article
- research article
- Published by Wiley in Biotechnology Progress
- Vol. 25 (3) , 735-744
Abstract
We describe a novel polyprotein precursor‐based approach to express antibodies from mammalian cells. Rather than expressing heavy and light chain proteins from separate expression units, the antibody heavy and light chains are contained in one single‐open reading frame (sORF) separated by an intein gene fused in frame. Inside mammalian cells this ORF is transcribed into a single mRNA, and translated into one polypeptide. The antibody heavy and light chains are separated posttranslationally, assembled into the functional antibody molecule, and secreted into culture medium. It is demonstrated that Pol I intein from P. horikoshii mediates protein splicing and cleavage reactions in mammalian cells, in the context of antibody heavy and light chain amino acid sequences. To allow the separation of antibody heavy chain, light chain, and the intein, we investigated a number of intein mutations designed to inhibit intein‐mediated splicing but preserve cleavage reactions. We have also designed constructs in which the signal peptide downstream from intein has altered hydrophobicity. The use of some of these mutant constructs resulted in more efficient antibody secretion, highlighting areas that can be further explored in improving such an expression system. An antibody secreted using one of the sORF constructs was characterized. This antibody has correct N‐terminal sequences for both of its heavy and light chains, correct heavy and light chain MW as well as intact MW as measured by mass spectrometry. Its affinity to antigen, as measured by surface plasmon resonance (SPR), is indistinguishable from that of the same antibody produced using conventional method. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009Keywords
This publication has 35 references indexed in Scilit:
- An Antibody Delivery System for Regulated Expression of Therapeutic Levels of Monoclonal Antibodies In VivoMolecular Therapy, 2007
- Various Expression-Augmenting DNA Elements Benefit from STAR-Select, a Novel High Stringency Selection System for Protein ExpressionBiotechnology Progress, 2007
- Employing epigenetics to augment the expression of therapeutic proteins in mammalian cellsTrends in Biotechnology, 2006
- Protein Splicing Mechanisms and ApplicationsIUBMB Life, 2005
- Stable antibody expression at therapeutic levels using the 2A peptideNature Biotechnology, 2005
- Kinetic Analysis of the Individual Steps of Protein Splicing for the Pyrococcus abyssi PolII InteinJournal of Biological Chemistry, 2005
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- IRES Bicistronic Expression Vectors for Efficient Creation of Stable Mammalian Cell LinesBiochemical and Biophysical Research Communications, 1996
- Protein Splicing Involving the Saccharomyces cerevisiae VMA InteinJournal of Biological Chemistry, 1996
- Specific interaction between enhancer-containing molecules and cellular componentsCell, 1984